NCT01244191 2021-04-06Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung CancerDaiichi SankyoPhase 3 Terminated1,048 enrolled 15 charts